Business
MARA Stock Surges Nearly 5% to $10.02 as Bitcoin Miner Pushes AI Pivot Amid Debt Reduction
NEW YORK — Shares of MARA Holdings Inc. jumped Monday to $10.02, up 48 cents or 4.98%, as the Bitcoin mining company continued to draw trader interest following its aggressive balance sheet cleanup, strategic shift toward artificial intelligence infrastructure and ongoing volatility tied to cryptocurrency prices.

The Miami-based firm, formerly known as Marathon Digital Holdings, has been transforming from a pure-play Bitcoin miner into a broader digital energy and infrastructure player. Its latest moves include selling a significant portion of its Bitcoin treasury to retire convertible debt at a discount and forging partnerships aimed at repurposing mining sites for high-performance computing and AI data centers.
MARA’s stock has been highly volatile in 2026, trading in a 52-week range from about $6.66 to $23.45. Monday’s gain came on elevated volume as investors weighed the company’s reduced leverage against persistent challenges in its core mining operations and broader sector pressures.
On March 26, MARA announced it had sold 15,133 Bitcoin between March 4 and March 25 for approximately $1.1 billion. The company used the proceeds to fund the repurchase of roughly $1 billion in face value of its 0.00% convertible senior notes due in 2030 and 2031. The notes were bought back at a discount, allowing MARA to capture about $88 million in value while reducing potential future dilution from conversions.
CEO Fred Thiel described the transaction as a “strategic capital allocation move” designed to strengthen the balance sheet and position the company for long-term growth. After the sales, MARA held approximately 38,689 Bitcoin, down from 53,822 at the end of 2025. The company has signaled it may continue opportunistically monetizing Bitcoin holdings in 2026 to enhance liquidity and fund initiatives.
The debt reduction lowers outstanding convertible principal significantly, easing pressure on the equity base. Analysts noted the move as credit-positive, though some expressed concern that selling treasury Bitcoin signals a departure from the aggressive accumulation strategy that once defined the company.
MARA has also been pivoting toward AI and high-performance computing. In late February, the company announced a strategic partnership with Starwood Capital to develop, lease and market select U.S. Bitcoin mining data centers for hyperscale, enterprise and AI-capable infrastructure. The arrangement includes triggers for proceeding with development, such as securing leases with qualifying tenants, with a decision required within 24 months.
The pivot comes after MARA reported a massive $1.71 billion net loss for the fourth quarter of 2025, driven largely by impairment charges and unrealized losses on digital assets amid fluctuating Bitcoin prices. For the full year 2025, revenue rose to about $907 million from $656 million the prior year, but the company swung to a $1.31 billion net loss from prior profitability.
Bitcoin production in Q4 fell 19% year-over-year to 2,011 BTC, reflecting operational challenges including power constraints and efficiency efforts. Adjusted EBITDA turned negative, highlighting the impact of lower hash rates and higher costs in a competitive mining environment.
Despite the headline losses, shares rose sharply after the earnings release as investors focused on the AI infrastructure narrative and the Starwood deal. Management has emphasized that its energy assets and sites provide a foundation for diversification beyond mining, potentially generating stable leasing revenue from AI hyperscalers seeking power-hungry data centers.
Analyst reactions have been mixed. Cantor Fitzgerald maintained an Overweight rating but lowered its price target to $10 from $11 in early April. The consensus 12-month price target sits around $16.48, suggesting potential upside from current levels, though forecasts vary widely given the company’s sensitivity to Bitcoin prices and execution risks on the AI pivot.
MARA is scheduled to report first-quarter 2026 results around May 7. Wall Street expects continued focus on hash rate recovery, Bitcoin holdings updates, progress on the Starwood partnership and any further treasury transactions.
The company’s digital asset management strategy has included lending and pledging portions of its Bitcoin stack, generating interest income. At year-end 2025, about 28% of holdings were activated in such programs. While this provides yield, it also introduces counterparty and custody risks.
Broader market context has influenced MARA’s performance. Bitcoin prices have fluctuated in 2026 amid macroeconomic uncertainty, regulatory developments and institutional adoption trends. MARA’s valuation remains closely tied to crypto sentiment, even as it attempts to decouple through infrastructure diversification.
Insider activity has added to the narrative. In mid-March, CEO Fred Thiel sold 27,505 shares under a pre-arranged 10b5-1 trading plan at an average price of $9.18. Such sales are routine for executives but can sometimes weigh on sentiment in a volatile name.
MARA operates large-scale mining facilities across the United States, leveraging low-cost power agreements where possible. The company has highlighted improvements in energy efficiency and fleet upgrades, though production declines in recent quarters reflect industry-wide headwinds including the Bitcoin halving effects and rising competition.
The AI pivot introduces both opportunity and risk. Repurposing mining sites could generate higher-margin revenue from leasing, but it may divert power and resources from Bitcoin mining, potentially reducing output further. Operational disruptions during transitions could also pressure near-term results.
Critics argue MARA remains primarily a leveraged Bitcoin play, with its treasury and mining operations still dominating the story. Supporters point to the company’s substantial power capacity and site portfolio as undervalued assets in an era of surging AI demand for data center infrastructure.
As of mid-April 2026, MARA’s market capitalization hovers around $3.6 billion, with an enterprise value higher due to remaining debt. The stock carries a high beta, making it prone to sharp swings on crypto news, earnings or sector developments.
Looking ahead, key catalysts include Q1 production figures, updates on AI leasing progress, any additional Bitcoin sales or purchases, and macroeconomic factors affecting Bitcoin. Success in securing hyperscaler tenants for its data centers could mark a meaningful step in the strategic transformation.
Challenges persist, including regulatory scrutiny on crypto mining energy use, competition from larger players like Riot Platforms, and the inherent volatility of digital assets. Workforce reductions of about 15% announced earlier signal cost discipline amid the pivot.
MARA’s story reflects broader trends in the Bitcoin mining sector, where many operators are exploring diversification into AI, HPC or other energy-intensive applications to stabilize revenue. Whether the company can successfully execute this shift while managing its remaining Bitcoin exposure will determine if it can command a premium valuation beyond its crypto roots.
For now, with shares rebounding toward the $10 level on Monday and first-quarter earnings approaching, MARA remains one of the most actively traded names at the intersection of cryptocurrency, energy infrastructure and emerging AI data center demand. Investors continue to debate whether the balance sheet cleanup and AI ambitions provide a sustainable path forward or if the company will stay tethered to Bitcoin’s fortunes.
Business
Sigma Foods acquires smoked meats producer

Roger Wood is the No. 1 smoked sausage company in the southeast United States, according to Sigma.
Business
Scorpio Tankers faces earnings test as war drives record rates

Scorpio Tankers faces earnings test as war drives record rates
Business
Earnings call transcript: FTI Consulting Q1 2026 misses EPS, revenue beats

Earnings call transcript: FTI Consulting Q1 2026 misses EPS, revenue beats
Business
Form 144 ENSIGN GROUP For: 4 May

Form 144 ENSIGN GROUP For: 4 May
Business
Celcuity Stock Soars 14% to $143 on Positive Phase 3 Breast Cancer Trial Data
NEW YORK — Celcuity Inc. shares surged more than 13.8 percent to $143 in early trading Monday, May 4, 2026, after the clinical-stage oncology company announced that its Phase 3 VIKTORIA-1 trial met the primary endpoint with clinically meaningful improvement in progression-free survival for patients with PIK3CA-mutant advanced breast cancer. The positive topline results for gedatolisib sent the biotech stock to new highs and reignited investor enthusiasm for the company’s targeted therapy pipeline just weeks before a potential FDA submission.
Celcuity reported that both the gedatolisib triplet and doublet regimens demonstrated statistically significant and clinically meaningful improvement in progression-free survival compared to the control arm in the PIK3CA mutant cohort. The data, released late Friday, May 1, triggered a sharp after-hours rally that carried into Monday’s session. The company said the results support advancing toward a supplemental New Drug Application (sNDA) filing with the FDA, with a potential PDUFA target in July 2026.
The VIKTORIA-1 trial evaluated gedatolisib in combination with standard therapies for HR+/HER2- advanced breast cancer patients who had progressed after prior CDK4/6 inhibitor treatment. Gedatolisib, a first-in-class PI3K/mTOR inhibitor, targets a pathway frequently altered in breast cancer. Positive data in the PIK3CA mutant population — a subgroup with historically poorer outcomes — positions the drug as a potential new standard of care option in a market estimated to exceed $5 billion annually at peak.
Celcuity CEO Brian Sullivan called the results a “transformational milestone” for the company and patients. “These data demonstrate gedatolisib’s potential to meaningfully improve outcomes in a population with significant unmet need,” Sullivan said in the company’s release. The firm is now accelerating commercial launch preparations while advancing additional indications for the drug across multiple solid tumors.
The stock reaction reflects high expectations. Celcuity has been on many biotech investors’ radars due to gedatolisib’s profile and its near-term regulatory timeline. Analysts have issued bullish price targets, with some projecting peak annual revenue exceeding $2.5 billion if the drug secures approval across multiple lines of therapy. Monday’s surge pushed the company’s market capitalization well above $6 billion.
The trial success comes at a pivotal time for Celcuity. The company has been advancing its precision medicine platform, which uses live tumor cell testing to identify patients most likely to benefit from targeted therapies. Gedatolisib represents the lead asset in this approach, and positive Phase 3 data significantly de-risks the program while strengthening its position ahead of potential partnership or commercialization discussions.
Broader market context amplified the move. Biotech stocks have shown renewed strength in 2026 amid improving regulatory sentiment and investor appetite for late-stage assets with clear paths to approval. Celcuity’s data stands out for its statistical robustness and clinical relevance in a competitive breast cancer landscape dominated by CDK4/6 inhibitors and antibody-drug conjugates.
Analysts reacted swiftly. Citizens initiated coverage with a Market Outperform rating and $150 price target earlier in the week, citing the drug’s potential. Other firms have highlighted the July 2026 PDUFA timeline as a key catalyst. While some caution remains around commercial execution and competition, the overall sentiment has turned increasingly bullish following the topline readout.
For patients and physicians, the results offer hope for better options in later-line HR+/HER2- breast cancer. PIK3CA mutations occur in approximately 40 percent of cases, and effective targeted therapies have been limited. Gedatolisib’s mechanism and tolerability profile could fill an important gap if approved.
Celcuity has cash reserves to support operations through key milestones, including potential approval and launch. The company continues enrolling patients in additional trials exploring gedatolisib in other settings and tumor types, positioning it for potential label expansion in the years ahead.
As trading continued Monday morning, volume remained elevated and the stock held near session highs. The move underscores the biotech sector’s sensitivity to clinical data, where positive Phase 3 readouts can drive outsized gains even in a broader market environment focused on macro signals and Federal Reserve policy.
Looking forward, all eyes are on the full dataset presentation at an upcoming medical meeting and the company’s regulatory strategy. If the FDA accepts the filing with priority review, approval could come as early as late 2026, setting the stage for Celcuity’s transition from clinical developer to commercial-stage oncology company.
The surge in Celcuity stock serves as a reminder of the high-reward potential in targeted oncology. For investors who backed the company through its development phase, Monday’s gains validate the long-term bet on gedatolisib. As the story unfolds, the biotech community will watch closely to see whether this positive momentum translates into sustained value creation in the competitive breast cancer market.
Business
Oatly concerned about ‘volatility’ of Middle East conflict on business

The company now has 30% retail share in US oat milk segment.
Business
US, EU Officials Hold Talks After Trump Raises Car Tariffs to 25%

US, EU Officials Hold Talks After Trump Raises Car Tariffs to 25%
Business
Key Trends Shaping Plant-Based Dairy Innovation

Addressing consumer expectations and overcoming formulation challenges in plant-based dairy.
Business
California Water: Dividend King Selling At A Discount (NYSE:CWT)
Founder of Bern Factor LLC, an independent research and publishing firm located in Virginia. Author of “Making Wall Street Irrelevant – Successful Investing Made Simple.” I have more than 40 years of investing and analysis experience. I am a former CPA (1990 -2017) and became a CFA charter holder in 2000. I consider myself an expert in Quantitative and Qualitative analysis and have extensive experience in Technical Analysis. I also have a deep interest in stock market history and hold degrees in Economics (BS) and Management Information Systems (MBA). I have been actively involved with investment analysis since 1985 but have been a student of investing since the 1960s. I owned my first individual stock position while still in high school. I am a student of Benjamin Graham and Warren Buffett. I have achieved a uniquely diverse experience from multiple careers that has allowed me to develop a broad perspective enabling me to look at the big picture of macroeconomics all the way down to the detail of a retail unit or factory floor. In my youth I was in retail, then served in reconnaissance during my tours in Vietnam. I have been a blue collar, union worker in a factory and a manager in services, hospitality and transportation as well as a manager of professional staffs. I have more than 20 years of experience each in both the public and private sectors. I have personal points of reference that many analysts will never have. I bring more to the table than just the theories and models I have studied or built.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Short position through short-selling of the stock, or purchase of put options or similar derivatives in CWT over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
DISCLAIMER: This analysis is not advice to buy or sell this or any stock; it is just pointing out an objective observation of unique patterns that developed from our research. Factual material is obtained from sources believed to be reliable, but the poster is not responsible for any errors or omissions, or for the results of actions taken based on information contained herein. Nothing herein should be construed as an offer to buy or sell securities or to give individual investment advice.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
Exxon Mobil: A Rising Oil Bet
Exxon Mobil: A Rising Oil Bet
-
Tech7 days agoRegister Renaming | Hackaday
-
Politics7 days agoDrax board avoid their own AGM, accused of greenwashing & environmental racism
-
Fashion6 days agoKylie Jenner’s KHY Enters a New Era with ‘Born in LA’
-
NewsBeat20 hours agoChannel 5 – All Creatures Great and Small series 7 new post
-
Tech7 days agoImages of Samsung’s rumored smart glasses have leaked
-
Tech3 days agoTrump’s 25% EU auto tariff breaches Turnberry Agreement that also covers semiconductors and digital trade
-
Business6 days agoMost Commercial Energy Audits Miss the Real Losses
-
Crypto World6 days agoCFTC’s AI will review U.S. crypto registration applications, chairman tells CoinDesk
-
Sports3 days agoPaul Scholes issues Marcus Rashford reality check as agreement emerges over Man United star
-
Business5 days agoBarclay Brothers Avoid Bankruptcy: HSBC Drops High Court Petitions After IVA Deal
-
Business5 days agoTesla Officially Registers Elon Musk’s Stock: What Investors Need to Know
-
Tech6 days agoGet Ready for More Brain-Scanning Consumer Gadgets
-
Crypto World6 days agoRobinhood Phishing Scam Exploits Gmail Dot Feature to Bypass Security
-
Entertainment7 days agoSister Wives: Janelle Posts New Scary Warning
-
Crypto World6 days agoGmail Dot Trick Underpins Robinhood Phishing, Sending Real-Looking Emails
-
Entertainment7 days agoMichael Jackson’s Biopic Excluded Abuse Allegations For $25M
-
Business4 days agoTwo Powerball Tickets Split $143 Million Jackpot in Indiana and Kansas
-
Business7 days agoSuperdry co-founder accused of raping woman
-
Crypto World7 days agoMeme Coin Based on White House Shooter Conspiracy Rallies 320%
-
Entertainment7 days ago
5 Movies Turning 20 That We’d Rather Forget About

You must be logged in to post a comment Login